Amyloid-beta E22Delta variant induces synaptic alteration in mouse hippocampal slices

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Familial Alzheimer's-type dementia is linked to mutations in amyloid precursor protein (APP).
• A specific APP mutation, E693Delta, results in an amyloid-beta (Abeta) variant lacking glutamate at position 22 (E22Delta).
• This Abeta E22Delta variant exhibits distinct aggregation properties, including enhanced oligomerization without fibrillization.

Purpose of the Study:

• To investigate the in vitro toxicity of the Abeta E22Delta peptide.
• To compare the neurotoxic effects of Abeta E22Delta with wild-type Abeta1-42.

Main Methods:

• Utilized the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT) assay to assess cytotoxicity in cultured neuronal cells.
• Examined the effects of Abeta peptides on synaptophysin levels in mouse hippocampal slices.

Main Results:

• Wild-type Abeta1-42 demonstrated dose-dependent cytotoxicity to neuronal cells.
• Abeta E22Delta showed only weak cytotoxicity at high concentrations (1 microM) in the MTT assay.
• In mouse hippocampal slices, Abeta E22Delta significantly decreased synaptophysin levels in a dose-dependent manner.
• Wild-type Abeta1-42 was trophic at lower concentrations (0.1-1 microM) but toxic at higher concentrations (10 microM) in hippocampal slices.

Conclusions:

• Extracellular Abeta E22Delta induces more potent synaptic alterations compared to wild-type Abeta1-42.
• Abeta E22Delta appears to cause lower overall neurodegeneration than wild-type Abeta1-42.
• The unique aggregation properties of Abeta E22Delta likely underlie its distinct toxicity profile.